Archive

Neovasc Announces TSX Symbol Change to NVCN

NASDAQ: NVCNTSX: NVC VANCOUVER, March 10, 2017 /CNW/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN) (TSX: NVC) today announced that effective at the opening of trading on Monday, March 13, 2017, shares of Neovasc will commence trading on the Toronto Stock Exchange ("TSX") under...

Read More

Neovasc to Present at the Leerink Partners Global Healthcare Conference

NASDAQ: NVCNTSX: NVC VANCOUVER, Feb. 15, 2017 /CNW/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN) (TSX: NVC) today announced that Alexei Marko, chief executive officer, is scheduled to present at the LEERINK Partners 6th Annual Global Healthcare Conference on Thursday, February 16th at 9:00...

Read More

Neovasc Announces Update in Litigation with CardiAQ

NASDAQ: NVCNTSX: NVC VANCOUVER, Jan. 18, 2017 /CNW/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN) (TSX: NVC) today announced an update in its ongoing litigation with CardiAQ Valve Technologies, Inc. ("CardiAQ"). On January 18, 2017, in the litigation filed against the Company by CardiAQ in...

Read More

Neovasc Announces Update in Litigation with CardiAQ

NASDAQ: NVCNTSX: NVC  VANCOUVER, Dec. 23, 2016 /CNW/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN) (TSX: NVC) reported today that the United States District Court for the District of Massachusetts has granted a stay of judgment pending the completion of its appeal. The judgment stems...

Read More

Neovasc Regains Compliance with NASDAQ Listing Requirements

NASDAQ: NVCNTSX: NVC VANCOUVER, Dec. 19, 2016 /CNW/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN) (TSX: NVC) announced today that the Company has regained compliance with the listing requirements of The NASDAQ Stock Market LLC ("Nasdaq"). As previously reported, on July 5, 2016, Neovasc received...

Read More

Neovasc and Boston Scientific Close US$75 Million Agreement

NASDAQ: NVCNTSX: NVC VANCOUVER, Dec. 13, 2016 /CNW/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN) (TSX: NVC) today announced the close of its transaction with Boston Scientific Corporation (NYSE: BSX). The two organizations announced a definitive agreement on December 2, 2016 for Boston Scientific to acquire...

Read More

Neovasc Provides Update on its Tiara™ Mitral Valve Clinical Program

-Recent results presented at the ICI Meeting in Israel- NASDAQ: NVCNTSX: NVC VANCOUVER, Dec. 6, 2016 /CNW/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN) (TSX: NVC) today provided an update on the clinical experience with its Tiara™ transcatheter mitral valve.  Tiara™ is a novel transcatheter...

Read More

Neovasc and Boston Scientific Reach US$75 Million Agreement

- Boston Scientific acquires tissue processing capabilities and takes equity stake in Neovasc - NASDAQ: NVCNTSX: NVC VANCOUVER, Dec. 2, 2016 /CNW/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN) (TSX: NVC) today announced that Boston Scientific Corporation (NYSE: BSX), a global medical technology leader, has...

Read More